NYSE:BCSF - Bain Capital Specialty Finance Stock Price, Forecast & News

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BCSF shares have decreased by 34.8% and is now trading at $10.98. View which stocks have been mosted impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bain Capital Specialty Finance.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance Inc (NYSE:BCSF) posted its earnings results on Wednesday, February, 26th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. The firm had revenue of $54.77 million for the quarter, compared to analyst estimates of $55.50 million. Bain Capital Specialty Finance had a net margin of 49.55% and a return on equity of 8.32%. View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, February 26th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.41 per share on Thursday, April 30th. This represents a $1.64 dividend on an annualized basis and a yield of 14.94%. The ex-dividend date of this dividend is Monday, March 30th. View Bain Capital Specialty Finance's dividend history.

3 brokers have issued twelve-month price objectives for Bain Capital Specialty Finance's stock. Their forecasts range from $9.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's stock price to reach $14.50 in the next twelve months. This suggests a possible upside of 32.1% from the stock's current price. View analysts' price targets for Bain Capital Specialty Finance.

News stories about BCSF stock have trended extremely negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bain Capital Specialty Finance earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutBain Capital Specialty Finance.

Bain Capital Specialty Finance saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 612,700 shares, an increase of 68.3% from the February 27th total of 364,000 shares. Based on an average daily volume of 300,100 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.2% of the shares of the stock are short sold. View Bain Capital Specialty Finance's Current Options Chain.

Some companies that are related to Bain Capital Specialty Finance include Vivint Smart Home (VVNT), Verra Mobility (VRRM), GS ACQUISITION /SH CL A (GSAH), Immunovant (IMVT), AdaptHealth (AHCO), HAYMAKER ACQUIS/SH CL A (HYAC), Global Cord Blood (CO), Gores Holdings III (GRSH), Pivotal Acquisition (PVT), FORUM MERGER II/SH CL A (FMCI), Andina Acquisition Corp. III (AMCI), Crescent Capital BDC (CCAP), New Frontier Health (NFH), Grid Dynamics (GDYN) and Kaleyra (KLR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Energy Transfer LP Unit (ET), Cisco Systems (CSCO), Alibaba Group (BABA), CVS Health (CVS), Walt Disney (DIS), AT&T (T), AbbVie (ABBV), Honeywell International (HON) and Altria Group (MO).

(BCSF) raised $156 million in an IPO on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities acted as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by a number of institutional and retail investors. Top institutional investors include Dimension Capital Management LLC (7.69%), Employees Retirement System of Texas (6.27%), UBS Group AG (4.20%), Bank of America Corp DE (1.52%), Starr International Co. Inc. (1.39%) and Muzinich & Co. Inc. (0.78%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough. View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was sold by a variety of institutional investors in the last quarter, including Colony Group LLC, Employees Retirement System of Texas, Dimension Capital Management LLC, Partners Group Holding AG, Credit Suisse AG, Muzinich & Co. Inc., UBS Group AG, and Patton Albertson Miller Group LLC. View insider buying and selling activity for Bain Capital Specialty Finance.

BCSF stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE, One Charles Private Wealth Services LLC, Raymond James Financial Services Advisors Inc., Formidable Asset Management LLC, Spark Investment Management LLC, California Public Employees Retirement System, Russell Investments Group Ltd., and Oxford Asset Management LLP. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough. View insider buying and selling activity for Bain Capital Specialty Finance.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCSF stock can currently be purchased for approximately $10.98.

Bain Capital Specialty Finance has a market capitalization of $567.12 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.  View additional information about Bain Capital Specialty Finance.

The official website for Bain Capital Specialty Finance is http://www.baincapitalbdc.com/.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]